List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Pegfilgrastim Biosimilar Product Introduction
1.2 Market by Type
1.2.1 Global Pegfilgrastim Biosimilar Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy Treatment
1.2.3 Transplantation
1.3 Market by Application
1.3.1 Global Pegfilgrastim Biosimilar Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Mail-Order Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pegfilgrastim Biosimilar Sales Estimates and Forecasts 2017-2028
2.2 Global Pegfilgrastim Biosimilar Revenue Estimates and Forecasts 2017-2028
2.3 Global Pegfilgrastim Biosimilar Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pegfilgrastim Biosimilar Sales by Region
2.4.1 Global Pegfilgrastim Biosimilar Sales by Region (2017-2022)
2.4.2 Global Sales Pegfilgrastim Biosimilar by Region (2023-2028)
2.5 Global Pegfilgrastim Biosimilar Revenue by Region
2.5.1 Global Pegfilgrastim Biosimilar Revenue by Region (2017-2022)
2.5.2 Global Pegfilgrastim Biosimilar Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pegfilgrastim Biosimilar Sales by Manufacturers
3.1.1 Global Top Pegfilgrastim Biosimilar Manufacturers by Sales (2017-2022)
3.1.2 Global Pegfilgrastim Biosimilar Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pegfilgrastim Biosimilar in 2021
3.2 Global Pegfilgrastim Biosimilar Revenue by Manufacturers
3.2.1 Global Pegfilgrastim Biosimilar Revenue by Manufacturers (2017-2022)
3.2.2 Global Pegfilgrastim Biosimilar Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pegfilgrastim Biosimilar Revenue in 2021
3.3 Global Pegfilgrastim Biosimilar Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pegfilgrastim Biosimilar Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pegfilgrastim Biosimilar Sales by Type
4.1.1 Global Pegfilgrastim Biosimilar Historical Sales by Type (2017-2022)
4.1.2 Global Pegfilgrastim Biosimilar Forecasted Sales by Type (2023-2028)
4.1.3 Global Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
4.2 Global Pegfilgrastim Biosimilar Revenue by Type
4.2.1 Global Pegfilgrastim Biosimilar Historical Revenue by Type (2017-2022)
4.2.2 Global Pegfilgrastim Biosimilar Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
4.3 Global Pegfilgrastim Biosimilar Price by Type
4.3.1 Global Pegfilgrastim Biosimilar Price by Type (2017-2022)
4.3.2 Global Pegfilgrastim Biosimilar Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pegfilgrastim Biosimilar Sales by Application
5.1.1 Global Pegfilgrastim Biosimilar Historical Sales by Application (2017-2022)
5.1.2 Global Pegfilgrastim Biosimilar Forecasted Sales by Application (2023-2028)
5.1.3 Global Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
5.2 Global Pegfilgrastim Biosimilar Revenue by Application
5.2.1 Global Pegfilgrastim Biosimilar Historical Revenue by Application (2017-2022)
5.2.2 Global Pegfilgrastim Biosimilar Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
5.3 Global Pegfilgrastim Biosimilar Price by Application
5.3.1 Global Pegfilgrastim Biosimilar Price by Application (2017-2022)
5.3.2 Global Pegfilgrastim Biosimilar Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pegfilgrastim Biosimilar Market Size by Type
6.1.1 North America Pegfilgrastim Biosimilar Sales by Type (2017-2028)
6.1.2 North America Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
6.2 North America Pegfilgrastim Biosimilar Market Size by Application
6.2.1 North America Pegfilgrastim Biosimilar Sales by Application (2017-2028)
6.2.2 North America Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
6.3 North America Pegfilgrastim Biosimilar Market Size by Country
6.3.1 North America Pegfilgrastim Biosimilar Sales by Country (2017-2028)
6.3.2 North America Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pegfilgrastim Biosimilar Market Size by Type
7.1.1 Europe Pegfilgrastim Biosimilar Sales by Type (2017-2028)
7.1.2 Europe Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
7.2 Europe Pegfilgrastim Biosimilar Market Size by Application
7.2.1 Europe Pegfilgrastim Biosimilar Sales by Application (2017-2028)
7.2.2 Europe Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
7.3 Europe Pegfilgrastim Biosimilar Market Size by Country
7.3.1 Europe Pegfilgrastim Biosimilar Sales by Country (2017-2028)
7.3.2 Europe Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pegfilgrastim Biosimilar Market Size by Type
8.1.1 Asia Pacific Pegfilgrastim Biosimilar Sales by Type (2017-2028)
8.1.2 Asia Pacific Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
8.2 Asia Pacific Pegfilgrastim Biosimilar Market Size by Application
8.2.1 Asia Pacific Pegfilgrastim Biosimilar Sales by Application (2017-2028)
8.2.2 Asia Pacific Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
8.3 Asia Pacific Pegfilgrastim Biosimilar Market Size by Region
8.3.1 Asia Pacific Pegfilgrastim Biosimilar Sales by Region (2017-2028)
8.3.2 Asia Pacific Pegfilgrastim Biosimilar Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pegfilgrastim Biosimilar Market Size by Type
9.1.1 Latin America Pegfilgrastim Biosimilar Sales by Type (2017-2028)
9.1.2 Latin America Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
9.2 Latin America Pegfilgrastim Biosimilar Market Size by Application
9.2.1 Latin America Pegfilgrastim Biosimilar Sales by Application (2017-2028)
9.2.2 Latin America Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
9.3 Latin America Pegfilgrastim Biosimilar Market Size by Country
9.3.1 Latin America Pegfilgrastim Biosimilar Sales by Country (2017-2028)
9.3.2 Latin America Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Type
10.1.1 Middle East and Africa Pegfilgrastim Biosimilar Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
10.2 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Application
10.2.1 Middle East and Africa Pegfilgrastim Biosimilar Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
10.3 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Country
10.3.1 Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Overview
11.2.3 Mylan Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Mylan Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Recent Developments
11.3 Coherus BioSciences
11.3.1 Coherus BioSciences Corporation Information
11.3.2 Coherus BioSciences Overview
11.3.3 Coherus BioSciences Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Coherus BioSciences Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Coherus BioSciences Recent Developments
11.4 Mundipharma International
11.4.1 Mundipharma International Corporation Information
11.4.2 Mundipharma International Overview
11.4.3 Mundipharma International Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mundipharma International Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mundipharma International Recent Developments
11.5 Biocon
11.5.1 Biocon Corporation Information
11.5.2 Biocon Overview
11.5.3 Biocon Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biocon Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biocon Recent Developments
11.6 Intas Pharmaceuticals
11.6.1 Intas Pharmaceuticals Corporation Information
11.6.2 Intas Pharmaceuticals Overview
11.6.3 Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Intas Pharmaceuticals Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Dr Reddy?s Laboratories
11.8.1 Dr Reddy?s Laboratories Corporation Information
11.8.2 Dr Reddy?s Laboratories Overview
11.8.3 Dr Reddy?s Laboratories Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dr Reddy?s Laboratories Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dr Reddy?s Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pegfilgrastim Biosimilar Industry Chain Analysis
12.2 Pegfilgrastim Biosimilar Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pegfilgrastim Biosimilar Production Mode & Process
12.4 Pegfilgrastim Biosimilar Sales and Marketing
12.4.1 Pegfilgrastim Biosimilar Sales Channels
12.4.2 Pegfilgrastim Biosimilar Distributors
12.5 Pegfilgrastim Biosimilar Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pegfilgrastim Biosimilar Industry Trends
13.2 Pegfilgrastim Biosimilar Market Drivers
13.3 Pegfilgrastim Biosimilar Market Challenges
13.4 Pegfilgrastim Biosimilar Market Restraints
14 Key Findings in The Global Pegfilgrastim Biosimilar Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
